Atlas Venture Opportunity Fund II, L.P. - Insider Trading & Ownership

Entity
Company
Location
300 Technology Square, 8 Th Floor, Cambridge, Massachusetts
Summary
The estimated value of insider holdings of Atlas Venture Opportunity Fund II, L.P. is at least $90.8 M dollars as of April 23, 2024. Atlas Venture Opportunity Fund II, L.P. is the 10%+ Owner of Dyne Therapeutics, Inc. and owns shares of Dyne Therapeutics, Inc. (DYN) stock worth about $44.5 M. Atlas Venture Opportunity Fund II, L.P. is the 10%+ Owner of Day One Biopharmaceuticals, Inc. and owns shares of Day One Biopharmaceuticals, Inc. (DAWN) stock worth about $20.6 M. Atlas Venture Opportunity Fund II, L.P. is the 10%+ Owner of Disc Medicine, Inc. and owns shares of Disc Medicine, Inc. (IRON) stock worth about $14.8 M. Atlas Venture Opportunity Fund II, L.P. is the 10%+ Owner of Korro Bio, Inc. and owns shares of Korro Bio, Inc. (KRRO) stock worth about $10.9 M.
All Insider Reports
All Insider Reports

Ownership of Atlas Venture Opportunity Fund II, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DYN Dyne Therapeutics, Inc. 10%+ Owner $44.5 M Dec 12, 2022
DAWN Day One Biopharmaceuticals, Inc. 10%+ Owner $20.6 M Jun 17, 2022
IRON Disc Medicine, Inc. 10%+ Owner $14.8 M Dec 29, 2022
KRRO, FREQ Korro Bio, Inc. 10%+ Owner $10.9 M +$1 M +10.1% Apr 22, 2024

Insider Transactions Reported by Atlas Venture Opportunity Fund II, L.P.:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership